New drug cocktail tested for Tough-to-Treat cancers
NCT ID NCT05396833
Summary
This early-stage trial is testing new combinations of experimental cancer drugs in people with advanced solid tumors that have spread or cannot be removed by surgery. The main goal is to find safe doses and understand how the drugs work in the body. Researchers will also look for early signs that these combinations might help control certain cancers with specific genetic mutations.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC OR LOCALLY ADVANCED UNRESECTABLE SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Asan Medical Center
Seoul, 05505, South Korea
-
Augusta University - formerly Georgia Regents University
Augusta, Georgia, 30912, United States
-
Calvary Mater Newcastle - PARENT
Waratah, Australia
-
Carolina Urologic Research Center
Myrtle Beach, South Carolina, 29572, United States
-
Centro Integral Oncologico Clara Campal - Unidad de Fase I-Oncologica
Madrid, 28050, Spain
-
Hospital Clinic de Barcelona - Servicio de Oncologia
Barcelona, Spain
-
Hospital QuironSalud Barcelona - Next Oncology
Barcelona, 08023, Spain
-
Hospital Universitario Fundacion Jimenez Diaz - START Madrid FJD - Oncology Phase I
Madrid, Spain
-
Hospital Universitario Quironsalud Madrid - NEXT Oncology
Madrid, 28223, Spain
-
Korea University Guro Hospital
Seoul, 08308, South Korea
-
Mary Crowley Cancer Research Centers
Dallas, Texas, 75230, United States
-
NEXT Oncology
San Antonio, Texas, 78229, United States
-
Princess Margaret Cancer Centre
Toronto, M5G 2C1, Canada
-
Providence Medical Foundation
Santa Rosa, California, 95403, United States
-
Royal North Shore Hospital
St Leonards, Australia
-
Samsung Medical Center
Seoul, 06351, South Korea
-
Seoul National University Bundang Hospital
Seongnam-si, 13620, South Korea
-
Severance Hospital, Yonsei University Health System - Division of Infectious Diseases
Seoul, 03722, South Korea
-
The Catholic University of Korea, Seoul St. Mary's Hospital
Seoul, 06591, South Korea
-
The University of Kansas Medical Center Research Institute, Inc.
Kansas City, Kansas, 66205, United States
-
University of Miami School of Medicine
Miami, Florida, 33136, United States
-
University of Texas M. D. Anderson Cancer Center - Partner
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.